Serum Institute of India (SII) Current Affairs, GK & News

SII: Anti-cervical cancer vaccine

On July 12, 2022, the CEO of Serum Institute of India (SII) Adar Poonawalla announced company’s plans to roll out its indigenously-developed vaccine for the prevention of cervical cancer among women. Highlights The Drugs Controller General of India (DCGI) has also accorded the market authorisation to SII for manufacturing the vaccine for cervical cancer. It will be ..

Month: 

Category: 

Topics: 

Conditional market approval for Covaxin, Covishield

The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the vaccines will not be available in retail medical stores. What is conditional market authorisation? The Serum Institute vaccine COVISHELD and Bharat Biotech’s COVAXIN were administered in the ..

Month: 

Category: 

Topics: 

Padma Awards 2022

The Padma Awards 2022 is to be conferred to vaccine makers to semiconductor market rulers. This time, the Padma awards are being presented to a diversified list of recipients. Around 128 people are to receive the award in 2022. The awards will be presented by President Ram Nath Kovind at Rashtrapati Bhawan. Padma Vibhushan The ..

Month: 

Category: 

Topics: 

WHO gives emergency approval for Covovax vaccine

On December 17, 2021, World Health Organisation (WHO) gave approval for emergency use of Covovax vaccine for Children. Key Points WHO listed the Covovax as ninth COVID-19 vaccine for emergency use. This move is aimed at increasing the access to vaccination across lower-income countries. The Serum Institute of India (SII) produces Covovax, under the licence ..

Month: 

Category: 

Topics: 

Italy recognizes India’s Covishield Vaccine

Italy has recognised Covishield vaccine against the Coronavirus on September 24, 2021. Highlights Covieshield vaccine against coronavirus was jointly developed by Oxford University & pharma giant AstraZeneca while it was manufactured by the Serum Institute of India. With this recognition by Italy, Indian cardholders inoculated by covishield vaccine would now be eligible to get an ..

Month: 

Category: 

Topics: 

PM Modi on Time’s ‘100 most influential’ list

Prime Minister Narendra Modi have been named among 100 most influential people of 2021 by the Time Magazine. Key Points Apart from PM Modi, West Bengal Chief Minister Mamata Banerjee and CEO of Serum Institute of India, Adar Poonawalla have also been named among the world’s 100 most influential people. Time magazine unveiled its annual ..

Month: 

Category: 

Topics: